Oct 23, 2020, 09:06 by

Boston-based life sciences tech innovator builds on success of its elluminate® platform and ASCEND services to accelerate clinical trials

Oct 23, 2020, 09:06 by

ActiGraph, a leading global provider of medical-grade wearable physical activity and sleep monitoring solutions for pharmaceutical and academic research, announced the hiring of three key members of its executive leadership team. Joining ActiGraph are Kuno van der Post, Chief Commercial Officer, Lynda Barr, Chief Financial Officer, and Scott Ginnetti, Vice President of Human Resources and Culture.

Oct 23, 2020, 09:06 by

Oct 23, 2020, 09:06 by

Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, will share best practices and solutions to help sponsors get the most out of their hybrid, virtual and synthetic clinical trials in an upcoming webinar, “Mitigating COVID-19 through a hybrid decentralized clinical trials approach.” The webinar will take place on Wednesday, October 7, from 1-2 p.m. EST.

Oct 23, 2020, 09:06 by

Belgium-based AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with BIOCORP, a French company specialized in the design, development and manufacture of innovative medical devices. The alliance will further extend the comprehensive portfolio of smart solutions and connected devices available to effectively measure and manage medication adherence for patients and healthcare providers.

Oct 23, 2020, 09:00 by

Panthera Biopartners (Panthera) has completed a Series A funding round with Gresham House Ventures as a major investor. The capital raised will enable Panthera to further build out its network of clinical trial sites across the UK and overseas and increase its team of clinical trial experts in serving both pharma and patients.

Oct 23, 2020, 09:00 by

PRC Clinical has galvanized its brand and website to reflect its increasingly specialized, high-touch approach to early phase clinical research. The vision of PRC showcases its commitment to providing customized CRO service for pharmaceutical, biotech and medical device sponsors.

Oct 23, 2020, 09:00 by

TrialScope, the global leader in clinical trial disclosure and transparency management technology, has added Eisai to its growing customer roster.

Oct 23, 2020, 09:00 by

Ubiquitome, the only company outside the US, has received NIH RADx funds to develop its open RT-PCR the Liberty16 to test for COVID-19 in US hospitals and mobile labs

Oct 23, 2020, 09:00 by

Indica Labs announced today the launch of an enterprise-wide, cloud-based deployment of the HALO®, HALO AI, HALO Link and HALO AP software within the National Cancer Institute (NCI) – which I thought would be of interest to you and your readers. The existing on-premise HALO licenses at the NCI are siloed and only accessible to specific research groups. The new deployment has been designed to expand accessibility to hundreds of users within the NCI, managing millions of digital images and facilitating the analysis of thousands of images daily. Taking a cloud-based approach, the deployment also simplifies data sharing and enables real-time collaboration between the NCI and both internal and external researchers in ways that were not previously possible.

Oct 23, 2020, 09:00 by

Noxopharm is pleased to announce treatment of the first patient with its lead pipeline candidate, Veyonda®, in the Company’s Phase 1 NOXCOVID-1 study.

Oct 23, 2020, 09:00 by

Oct 23, 2020, 09:00 by

Oct 23, 2020, 09:00 by

Oct 23, 2020, 08:57 by

New in vitro Bioactivation Liver Response Assay used HEPATOPAC model to demonstrate utility of in vitro transcriptomic signature-based strategy in preclinical DILI risk assessment 

Oct 23, 2020, 08:56 by

Cytel is set to revolutionize clinical trial design planning with the launch of SolaraTM, a collaborative decision-support platform for greater development productivity and better business results. Overcoming a critical bottleneck in pharma & biotech The platform will fundamentally reimagine clinical trial design – a process renowned for its tight design timelines and the convoluted process of reaching stakeholder consensus on the most suitable trial design. The only platform of its kind The platform applies massive cloud computing power to rapidly explore an exponentially larger design space than is possible using traditional design methods. It is the only platform to integrate statistical and business considerations into the trial design process and includes intuitive visualization tools to optimize decision-making.

Oct 23, 2020, 08:56 by

Applications for this model include assessing drug candidates’ hepatotoxicity, and studying inflammation-related diseases 

Oct 23, 2020, 08:56 by

New ‘blockchain ecosystem’ has potential to track, from vein-to-vein, advanced therapies

Oct 23, 2020, 08:56 by

Oct 23, 2020, 08:56 by

SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology.